Literature DB >> 28682944

A Simplified Mortality Score Using Delta Neutrophil Index and the Thrombotic Microangiopathy Score for Prognostication in Critically Ill Patients.

Eun K Goag1, Jong W Lee2,3, Yun H Roh4, Ah Y Leem1, Song Y Kim1, Joo H Song1, Eun Y Kim1, Ji Y Jung1, Moo S Park1, Young S Kim1, Se K Kim1, Joon Chang1, Kyung S Chung1.   

Abstract

BACKGROUND: This study was conducted to assess the prognostic value of a simplified mortality score (SMS) using the delta neutrophil index (DNI) and thrombotic microangiopathy (TMA) score, both easily obtained from the complete blood count, to identify critically ill patients at high risk of death.
METHODS: This was a retrospective study performed in the medical ICU at Yonsei University College of Medicine from June 2015 to February 2016. The primary end point was 28-day all-cause mortality. Participants were divided into two groups: a training (n = 232) and a test (n = 57) set. We used Cox proportional-hazards analysis, Harrell's C index, and Kaplan-Meier survival analysis to derive the SMS and test its internal validity.
RESULTS: We enrolled 289 patients. The 28-day mortality rate was 31.1% (n = 90). Nonsurvivors had higher APACHE II, SOFA, and TMA scores, and DNI. The SMS, derived by Cox proportional-hazards analysis, consisted of age, sex, DNI, and TMA score. We assigned a weighted point to each variable in the SMS, as follows: age + 11 if male + (2 × DNI) + (61 [TMA = 1], 76 [TMA = 2], 74 [TMA = 3], 26 [TMA = 4], 99 [TMA = 5]). Nonsurvivors had a higher median SMS than survivors, and the Harrell's C index was 0.660. Analysis of survival by risk group according to SMS (low, intermediate, high risk) showed a significant difference among these three groups (P < 0.001). We then investigated this SMS in the test set to determine internal validity; the results were similar to those of the training set.
CONCLUSIONS: The SMS is a more rapid, simple prognostic score for predicting 28-day mortality and stratifying risk than the APACHE II or SOFA scores. However, external validation using a larger sample is needed.

Entities:  

Mesh:

Year:  2018        PMID: 28682944     DOI: 10.1097/SHK.0000000000000936

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  3 in total

1.  Immature granulocytes as biomarkers of inflammation in children with predialysis chronic kidney disease.

Authors:  Nuran Cetın; Evin Kocaturk; Aslı Kavaz Tufan; Zeynep Kusku Kıraz; Ozkan Alatas
Journal:  Pediatr Nephrol       Date:  2022-04-20       Impact factor: 3.714

2.  Usefulness of the Thrombotic Microangiopathy Score as a Promising Prognostic Marker of Septic Shock for Patients in the Emergency Department.

Authors:  Dong Ryul Ko; Taeyoung Kong; Hye Sun Lee; Sinae Kim; Jong Wook Lee; Hyun Soo Chung; Sung Phil Chung; Je Sung You; Jong Woo Park
Journal:  J Clin Med       Date:  2019-06-06       Impact factor: 4.241

3.  Thrombotic Microangiopathy Score as a New Predictor of Neurologic Outcomes in Patients after Out-of-Hospital Cardiac Arrest.

Authors:  Je Sung You; Hye Sun Lee; Soyoung Jeon; Jong Wook Lee; Hyun Soo Chung; Sung Phil Chung; Taeyoung Kong
Journal:  Yonsei Med J       Date:  2022-05       Impact factor: 3.052

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.